Key protein behind chemotherapy resistance in colorectal cancer identified

AI Summary

Researchers have identified a key protein responsible for chemotherapy resistance in colorectal cancer, particularly to the widely used drug 5-fluorouracil (5-FU). This discovery may inform new approaches to overcome drug resistance and improve patient outcomes.

One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients. However, repeated treatment often leads to drug resistance, allowing cancer cells to adapt and gradually evade the effects of therapy.